A rapid, efficient, and highly accurate assay by neutronactivation analysis is presented for aluminum content as a function of the aluminum compounds contained in complex antibiotic formulations. The assay requires no chemical isolation or cleanup. The relatively short half-life of "A1 allows rapid
Radiolabelling of pharmaceutical dosage forms by neutron activation of samarium-152
β Scribed by M B Awang; J G Hardy; S S Davis; I R Wilding; S J Parry
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- French
- Weight
- 303 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Samariumβ152 can be activated in a neutron flux for the labelling of pharmaceutical dosage forms for evaluation by gamma scintigraphy. The samarium is incorporated as samarium oxide powder which is available with ^152^Sm in its natural isotopic abundance or isotopically enriched. The yield of ^153^Sm was reduced considerably following the neutron activation of the nonβisotopically enriched oxide. This can be attributed to the high neutron capture by ^149^Sm present in the nonβisotopically enriched oxide. In order to keep the mass of the added oxide powder to the minimum and also to reduce the neutron irradiation time, it is recommended that samarium oxide enriched with ^152^Sm should be used routinely when radiolabelling pharmaceutical dosage forms.
π SIMILAR VOLUMES